Ms. Sunny Strasburg, LMFTI Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 660 S 200 E Ste 308, Salt Lake City, UT 84111 Phone: 801-355-2846 |
Matthew Barkdull Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 132 S State St, Suite 100, Salt Lake City, UT 84111 Phone: 801-240-6296 |
Ms. Leni Quarnberg, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 E South Temple, Suite 101, Salt Lake City, UT 84111 Phone: 801-597-7729 Fax: 801-364-1433 |
Mr. Machiel Pieter Klerk, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2010 Evergreen Ave, Salt Lake City, UT 84109 Phone: 801-656-8806 |
Mr. Eric Carl Einhorn, LAMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5411 S Vine St # 6, Salt Lake City, UT 84107 Phone: 541-490-3237 |
Kate Johnson, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 4505 S Wasatch Blvd Ste 290, Salt Lake City, UT 84124 Phone: 385-695-5949 |
Steven Short Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S, Salt Lake City, UT 84111 Phone: 801-428-4257 |
Mr. Martin Thomas O Donnell Jr., LCSW Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 132 South State Street, Suite 100, Salt Lake City, UT 84111 Phone: 801-240-6500 Fax: 801-240-5508 |
Mr. John Richard Macfarlane Sr., LCSW MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 508 E South Temple, Suite 201, Salt Lake City, UT 84102 Phone: 801-328-8817 Fax: 801-366-4284 |
News Archive
Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston have discovered that malignant melanoma, the potentially lethal skin cancer, can't grow without a steady supply of a protein that normal cells can do without.
Recent media reports are suggesting that a diet high in fruits and vegetables and low in fat has no notable impact on breast cancer recurrence or death.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Using human cells, they have mapped how different proteins bind along the DNA to control which genes are active during barrier formation.
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
› Verified 5 days ago